Finance

Beta
Lists
NOX:ASX
Noxopharm Ltd
A$0.081
+3.85%
(+0.0030) 1D
Jun 5, 4:10:02 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for NOX...
Open
A$0.08
High
A$0.08
Low
A$0.08
Mkt. cap
24.26M
Avg. vol.
221.69K
Volume
410.60K
52-wk high
A$0.14
52-wk low
A$0.04
EPS
-A$0.02
Shares outstanding
307.24M
No. of employees
1K
Open
A$0.08
High
A$0.08
Low
A$0.08
Mkt. cap
24.26M
Avg. vol.
221.69K
Volume
410.60K
52-wk high
A$0.14
52-wk low
A$0.04
EPS
-A$0.02
Shares outstanding
307.24M
No. of employees
1K
News stories
From sources across the web
About Noxopharm Ltd
CEOGisela Mautner
Employees1K
Founded2015
HeadquartersCastle Hill, New South Wales, Australia
SectorBiotechnology
Websitenoxopharm.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
832.34K
832.34K
865.44K
865.44K
Cost of goods sold
1.36M
1.36M
814.91K
814.91K
Cost of revenue
1.36M
1.36M
814.91K
814.91K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.04M
1.04M
694.28K
694.28K
Operating expense
1.04M
1.04M
694.72K
694.72K
Total operating expenses
2.40M
2.40M
1.51M
1.51M
Operating income
-1.56M
-1.56M
-644.20K
-644.20K
Other non operating income
266.00K
266.00K
-19.92K
-19.92K
EBT including unusual items
-1.82M
-1.82M
-920.72K
-920.72K
EBT excluding unusual items
-1.49M
-1.49M
-920.72K
-920.72K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.82M
-1.82M
-920.72K
-920.72K
Net profit margin
-219.16%
-219.16%
-106.39%
-106.39%
Earnings per share
-
-
-
-
Interest and investment income
1.58K
1.58K
1.70K
1.70K
Interest expense
-214.94K
-214.94K
-250.29K
-250.29K
Net interest expenses
-213.36K
-213.36K
-248.58K
-248.58K
Depreciation and amortization charges
432.00
432.00
440.00
440.00
EBITDA
-1.56M
-1.56M
-643.76K
-643.76K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer